Ursodiol Suppliers & Bulk Manufacturers
Available Forms: Tablets / Capsule / Oral suspension
Available Strengths: 200mg, 300mg, 400mg, 250mg, 500mg, 150 mg/5 mL 300 mg/5 mL
Reference Brands: Actigall (USA), Urso (EU/UK), Ursofalk (EU/UK)
Category:
Gastrointestinal Drugs
Ursodiol, also known as ursodeoxycholic acid (UDCA), is a naturally occurring bile acid that is used therapeutically to treat various liver and gallbladder conditions. It is synthetically derived and functions by reducing the cholesterol content in bile, thereby promoting the dissolution of cholesterol gallstones and improving bile flow.
Ursodiol is available in Tablets / Capsule / Oral suspension
and strengths such as 200mg, 300mg, 400mg, 250mg, 500mg, 150 mg/5 mL 300 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ursodiol is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ursodiol can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ursodeoxycholic acid (UDCA), also known as ursodiol, is a bile acid medication used in the management and treatment of various cholestatic liver diseases. It is commonly prescribed for conditions such as primary biliary cholangitis, gallstone dissolution in selected patients, and other disorders associated with impaired bile flow. Ursodeoxycholic acid works by reducing the production and absorption of cholesterol and by improving bile flow from the liver, which helps protect liver cells from damage caused by toxic bile acids. Its hepatoprotective properties make it an important therapeutic option in chronic liver conditions.
UDCA also helps stabilize liver function and can slow the progression of certain liver diseases when used as part of long-term management. The medication has anti-inflammatory and cytoprotective effects within the liver, contributing to improved bile secretion and reduced liver enzyme levels in many patients. It is generally administered orally and is well tolerated, with a favorable safety profile when used under medical supervision.
In clinical practice, ursodeoxycholic acid plays a significant role in managing cholestatic disorders and improving patient outcomes. Its mechanism of action, combined with its ability to enhance bile flow and reduce liver injury, makes it a valuable treatment option in hepatology and liver disease management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing